Clarke A. Economic impact of lupus. Am J Manag Care. 2001 Oct;7(16 Suppl):S496-501.
Colditz GA. Economic costs of obesity. Am J Clin Nutr. 1992 Feb;55(2 Suppl):503S-507S.
Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003 Feb 24;163(4):487-94.
Grant WB, Garland CF, Holick MF. Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem Photobiol. 2005 Nov-Dec;81(6):1276-86.
Heaney RP, Dowell MS, Bierman J, Hale CA, Bendich A.Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr. 2001 Jun;20(3):239-46.
Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003 Mar;26(3):917-32.
Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004 Jan;52(1):80-5.
Wang G, Zheng ZJ, Heath G, Macera C, Pratt M, Buchner D. Economic burden of cardiovascular disease associated with excess body weight in U.S. adults. Am J Prev Med. 2002 Jul;23(1):1-6.
Whetten-Goldstein K, Sloan FA, Goldstein LB, Kulas ED. A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler. 1998 Oct;4(5):419-25.
Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res. 1998 Mar;6(2):97-106.
Yelin E. Cost of musculoskeletal diseases: impact of work disability and functional decline. J Rheumatol Suppl. 2003 Dec;68:8-11.